Where does Roche Sequencing Solutions, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Roche Sequencing Solutions, Inc. ranks #1,528 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Roche Sequencing Solutions, Inc. hold?

Roche Sequencing Solutions, Inc. holds 273 US utility patents granted between 2017 and 2025, spanning 40 technology areas.

What is Roche Sequencing Solutions, Inc.'s Innovation Score?

Roche Sequencing Solutions, Inc. has an Innovation Score of 59.5 out of 100 (top 4% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Roche Sequencing Solutions, Inc.'s patent grant rate increasing or decreasing?

Roche Sequencing Solutions, Inc.'s recent grant velocity is +1079% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Roche Sequencing Solutions, Inc.'s patents?

Roche Sequencing Solutions, Inc.'s patents average 15.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Roche Sequencing Solutions, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Roche Sequencing Solutions, Inc.

Q: What technology areas does Roche Sequencing Solutions, Inc. focus on?

Roche Sequencing Solutions, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 212 patents, ranking #15 of 2,502 assignees active in that subclass. Grants appear in 40 CPC subclasses total.

USPTO PatentsView assignee record - 273 granted patents across 40 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Roche ranks #1,528 of 49,997 tracked US assignees by granted-patent volume, with 273 patents across 40 technology areas.

#1,528
of 49,997 US assignees by volume: Top 4%
by Innovation Score (59.5/100): 15.1
avg claims per patent: +1079%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1528 · US Corporation #1,528 · 273 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 273 grants
TOP-DECILE #1,528/49,997
PHOTO-FINISH Nabtesco
CPC-WIDE C12Q · 40 areas
INNOV-PAR 59.5/100
CLAIMS-RICH 15.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +1079% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nabtesco Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Roche’s 59.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 19.4 pts (33%) Velocity 8.7 pts (15%) Breadth 22.4 pts (38%) Claim depth 9.1 pts (15%)

Qualcomm Incorporated · highest

85
Docusign · near

59
Energous · near

59
Roche Sequencing… · this assignee

59
Tetra Laval… · near

59
Institute FOR… · near

59
3D Lighting… · lowest

7

What this shows Roche's Innovation Score is 59.5/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Roche?

Each dot is one of Roche’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Roche’s own 15.1 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Roche vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Roche's grants concentrate

Roche Sequencing Solutions, Inc. is a focused PatentsView assignee: 40 CPC subclasses with 77.7% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2023 (54 grants) versus a trough of 1 in 2017. By volume, Roche sits between Nabtesco Corporation and China University of Mining and Technology.

Roche's three-year grant acceleration

From 2019–2021 to 2022–2024, Roche Sequencing Solutions, Inc. moved from 104 to 135 grants (1.30x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #642. See the growth leaderboard.

Nabtesco

273
Omya International

273
Otsuka Pharmaceut…

273
Pearson Education

273
Valeo Schalter UN…

273
William Marsh Ric…

273
Roche Sequencing… ◀

273
Acclarent

272
China University…

272

What this shows Roche holds 273 patents at rank #1,528, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Roche

By rank, the assignees closest to #1,528 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Roche's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Roche, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Roche ranks #15 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (59 here).

Energous Corporation 59 Tetra Laval Holdings & Finance S.A. 59 Docusign, Inc. 59 Institute FOR Information Industry 59

Similar claim depth

Nearest assignees by average claims per patent (15.1 here).

Epcos AG 15.1 avg Florida State University Research Foundation, Inc. 15.1 avg Koenig & Bauer AG 15.1 avg TRW Automotive GMBH 15.1 avg

Roche's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

59 Top 4% higher than 96% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Roche Sequencing Solutions, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	0.4%
2018	3	1.1%
2019	15	5.5%
2020	39	14.3%
2021	50	18.3%
2022	31	11.4%
2023	54	19.8%
2024	50	18.3%
2025partial year	30	11.0%

Which technologies does Roche Sequencing Solutions, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 212

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 151

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 65

C07K - Peptides 34

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 30

C12Y - Enzymes 28

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 19

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 17

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 15

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 13

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 9

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 8

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 5

B81B - Microstructural Devices OR Systems, e.g. Micromechanical Devices 5

Top 15 of 40 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Roche Sequencing Solutions, Inc.'s patent record in context - here's where to go next.

Roche Sequencing Solutions, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 77.7% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #1,528 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Roche Sequencing Solutions, Inc. against Nabtesco Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 59.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.